OPTILUTIN, created in 2004 (Finland), from 33 sister brands and 17478 competing brands. The OPTILUTIN brand is owned by Santen Pharmaceutical, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is JP3336000009. The sector of OPTILUTIN is Drug Manufacturers.